JOIN NPACE
COMMUNITY VIRTUAL
DISPLAY HALL

Pharmacology

Meet your national and state pharmacology credit requirements with recordings from NPACE’s live pharmacology conferences. These sessions will help you improve or maintain prescribing skills as well as stay current with the latest in pharmacotherapeutics. 

You may filter by category, such as women’s health or diabetes, alphabetically or by date. Click the “View” button to read the Course Description, Course Objectives, Speaker information, CNE Information and Disclosures. 

Like what you see? Click “Register” and follow instructions to view the video recording for up to one year. Successful completion of the post-test is required for CE units to be granted.

On-Demand Pharmacology CE

Search by Type
Sort By

62 Results

  • (DEA) MATE Act - Substance Use Disorder Bundle

    In accordance with the Medication Access and Training Expansion (MATE) Act, beginning June 7, 2023, all providers who are registered with the DEA are required to complete 8 hours of training on the treatment and management of patients with opioid and other substance use disorders. This bundle fully satisfies this one-time requirement. 

    Total Credits: 9.0 contact hours; 8.5 are pharmacology

    $225

  • 2023 Clinical Essentials for new Clinicians bundle V2

    This is an essential package for all nurse practitioner students and new NPs. This package builds upon the first clinical essentials package and includes important primary care topics including, caring for LGBTQIA patients, antibiotic stewardship, orthopedics, depression, anxiety, pelvic exam issues in adolescents, common dermatologic disorders, contraceptive management, and orthopedics.

    Total Credits: 11.75 contact hours; 8.25 are pharmacology
    $290

  • Adolescent Substance Use Disorder

    Adolescent substance use has followed familiar trends for several decades with alcohol, nicotine, and cannabis leading other drugs in popularity. After several years of declining nicotine use, primarily via combustible cigarettes, recent data suggests a resurgence of nicotine use, primarily via e-cigarettes as well as a marked increase in cannabis use, likely corresponding with legalization efforts. Additionally, there has been an increase in hallucinogen use and the dangers of opioid use have heightened due to the rise of illicit fentanyl being brought in from outside the United States. This lecture will review the most recent Monitoring the Future study and discuss implications of adolescent substance use trends on healthcare providers.

    Credits: 1.50 Contact Hours; 1.50 are Pharmacology

    $40

  • Antibiotic Update 2023: Respiratory Infections in the Challenging Patient

    This session will provide the nurse practitioner with information regarding common pathogens implicated in AECB and community acquired pneumonia in the patient with underlying co-morbidities such as asthma, COPD and alcohol abuse.  Current recommendations regarding antimicrobial treatment options will be reviewed in detail.  National recommendations for obtaining chest x-ray and sputum for gram staining will also be discussed.

    Credits: 1.50 Contact Hours; 1.50 are Pharmacology

    $45

  • Atrial Fibrillation-Importance, recognition, and treatment

    Atrial fibrillation (AF) remains the most common heart arrhythmia in the general population and is associated with significant morbidity and mortality. Appropriate identification and treatment are critical to prevent potential devastating sort-and long-term outcomes. Practitioners in all areas of practice will encounter patients with various stages of AF, and therefore must be able to identify, classify and treat this common arrhythmia. This session will focus on the classification of AF, identification and various treatment and preventative options.

    Credits: 1.50 contact hours; 0.75 are pharmacology
    $40

  • August 2022 Pharmacology Update Conference (Recorded)

    At NPACE Pharmacology Update conference, you will fulfill your professional development and licensure needs, and access priceless context, insights, and real-world understanding of complex healthcare issues. Each session emphasizes relevant and evidence-based clinical knowledge as well as offers guidance by seasoned speakers connected to today’s practice and is open to interaction and discussion.

    Credits: 12 credits; 11 are pharmacology
    $325

  • Basic Lab Interpretation with Case Studies

    This presentation will discuss common laboratory studies utilizing a case-based method. Then review decision-making strategies including the selection of the most appropriate tests for the clinical presentation, based on the current evidence. Lastly, explore the interpretation of the potential findings and develop the best treatment plans as well as any necessary follow-up that may be needed based on the findings.

    Credits: 1.00 contact hours; 0.25 are pharmacology
    Release Date: March 1, 2021
    $27.50

  • Building the Bridge: Targeted Education to Address Knowledge Gaps Related to Drug-to-Drug Interactions When Treating Outpatients with COVID-19

    Pfizer Grant Funded Program

    The overall goal of this program is to deliver targeted educational interventions to (1) improve health outcomes among outpatients with COVID-19 by building skills, knowledge, and competencies of providers that serve them, and (2) address provider knowledge gaps related to Drug-to-Drug Interactions (DDIs) in COVID-19 treatment.

    Credits: 1.0 contact hours; 1.0 are pharmacology

    FREE

  • Cardiovascular pharmacology updates

    This session will review foundational principles of cardiovascular pharmacology and include both new medications and updated indications for cardiovascular medications Discussion will focus on medications used in the treatment of heart failure, coronary artery disease, atrial fibrillation and deep vein thrombosis.

    Credits: 1.50 contact hours; 1.50 are pharmacology
    $37.50

  • Cardiovascular Pharmacotherapeutics Update: Stroke Prevention in Atrial Fibrillation

    This session will look at stroke prevention in patients with atrial fibrillation. Discussion of the key differences in the pharmacologic profiles of various oral chronic anticoagulation agents that influence treatment selection for individual patients with atrial fibrillation who are at risk of stroke.

    Credits: 1.50 contact hours; 1.50 are pharmacology
    Release Date: March 1, 2021
    $37.50